186 related articles for article (PubMed ID: 21115211)
1. Synthesis and in vitro anti-tumor activity of new oxadiazole thioglycosides.
Abu-Zaied MA; El-Telbani EM; Elgemeie GH; Nawwar GA
Eur J Med Chem; 2011 Jan; 46(1):229-35. PubMed ID: 21115211
[TBL] [Abstract][Full Text] [Related]
2. Design, synthesis and biological evaluation of a novel series of 1,3,4-oxadiazole bearing N-methyl-4-(trifluoromethyl)phenyl pyrazole moiety as cytotoxic agents.
Puthiyapurayil P; Poojary B; Chikkanna C; Buridipad SK
Eur J Med Chem; 2012 Jul; 53():203-10. PubMed ID: 22542958
[TBL] [Abstract][Full Text] [Related]
3. An efficient synthesis and biological study of novel indolyl-1,3,4-oxadiazoles as potent anticancer agents.
Kumar D; Sundaree S; Johnson EO; Shah K
Bioorg Med Chem Lett; 2009 Aug; 19(15):4492-4. PubMed ID: 19559607
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and anticancer activities of novel 3,5-disubstituted-1,2,4-oxadiazoles.
Kumar D; Patel G; Johnson EO; Shah K
Bioorg Med Chem Lett; 2009 May; 19(10):2739-41. PubMed ID: 19376704
[TBL] [Abstract][Full Text] [Related]
5. Design, synthesis and pro-apoptotic antitumour properties of indole-based 3,5-disubstituted oxadiazoles.
Ziedan NI; Stefanelli F; Fogli S; Westwell AD
Eur J Med Chem; 2010 Oct; 45(10):4523-30. PubMed ID: 20705365
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and antitumor evaluation of some new 1,3,4-oxadiazole-based heterocycles.
Bondock S; Adel S; Etman HA; Badria FA
Eur J Med Chem; 2012 Feb; 48():192-9. PubMed ID: 22204901
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and anticancer activity of new [(Indolyl)pyrazolyl]-1,3,4-oxadiazole thioglycosides and acyclic nucleoside analogs.
El-Sayed WA; El-Sofany WI; Hussein HAR; Fathy NM
Nucleosides Nucleotides Nucleic Acids; 2017 Jul; 36(7):474-495. PubMed ID: 28613111
[TBL] [Abstract][Full Text] [Related]
8. Synthesis, structure, and bioactivity of N'-substituted benzylidene-3,4,5-trimethoxybenzohydrazide and 3-acetyl-2-substituted phenyl-5-(3,4,5-trimethoxyphenyl)-2,3-dihydro-1,3,4-oxadiazole derivatives.
Jin L; Chen J; Song B; Chen Z; Yang S; Li Q; Hu D; Xu R
Bioorg Med Chem Lett; 2006 Oct; 16(19):5036-40. PubMed ID: 16876405
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and antitumor activity of new dihydropyridine thioglycosides and their corresponding dehydrogenated forms.
Abbas HA; El Sayed WA; Fathy NM
Eur J Med Chem; 2010 Mar; 45(3):973-82. PubMed ID: 20004044
[TBL] [Abstract][Full Text] [Related]
10. Design and synthesis of benzimidazole analogs endowed with oxadiazole as selective COX-2 inhibitor.
Rathore A; Rahman MU; Siddiqui AA; Ali A; Shaharyar M
Arch Pharm (Weinheim); 2014 Dec; 347(12):923-35. PubMed ID: 25303727
[TBL] [Abstract][Full Text] [Related]
11. A facile access to novel steroidal 17-2'-(1',3',4')-oxadiazoles, and an evaluation of their cytotoxic activities in vitro.
Kovács D; Mótyán G; Wölfling J; Kovács I; Zupkó I; Frank É
Bioorg Med Chem Lett; 2014 Mar; 24(5):1265-8. PubMed ID: 24518189
[TBL] [Abstract][Full Text] [Related]
12. Part II: Design, synthesis and antitumor action of C3/C3 bisfluoroquinolones linked-cross 2, 5-[1, 3, 4]oxadiazole.
Hu GQ; Yang Y; Yi L; Wang X; Zhang ZQ; Xie SQ; Huang WL
Yao Xue Xue Bao; 2010 Aug; 45(8):1012-6. PubMed ID: 21348428
[TBL] [Abstract][Full Text] [Related]
13. Novel 5-(2-hydroxyphenyl)-3-substituted-2,3-dihydro-1,3,4-oxadiazole-2-thione derivatives: promising anticancer agents.
Aboraia AS; Abdel-Rahman HM; Mahfouz NM; El-Gendy MA
Bioorg Med Chem; 2006 Feb; 14(4):1236-46. PubMed ID: 16242340
[TBL] [Abstract][Full Text] [Related]
14. Part IV: Design, synthesis and antitumor activity of fluoroquinolone C-3 heterocycles: bis-oxadiazole methylsulfide derivatives derived from ciprofloxacin.
Hu GQ; Hou LL; Wang GQ; Duan NN; Wen XY; Cao TY; Yin J; Wang W; Xie SQ; Huang WL
Yao Xue Xue Bao; 2012 Aug; 47(8):1017-22. PubMed ID: 23162898
[TBL] [Abstract][Full Text] [Related]
15. Synthesis, biological evaluation, and molecular docking studies of 1,3,4-oxadiazole derivatives possessing 1,4-benzodioxan moiety as potential anticancer agents.
Zhang XM; Qiu M; Sun J; Zhang YB; Yang YS; Wang XL; Tang JF; Zhu HL
Bioorg Med Chem; 2011 Nov; 19(21):6518-24. PubMed ID: 21962523
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and biological evaluation of 1,2,5-oxadiazole N-oxide derivatives as hypoxia-selective cytotoxins.
Monge A; López de Ceráin A; Ezpeleta O; Cerecetto H; Dias E; Di Maio R; González M; Onetto S; Seoane G; Suescun L; Mariezcurrena R
Pharmazie; 1998 Nov; 53(11):758-64. PubMed ID: 9853357
[TBL] [Abstract][Full Text] [Related]
17. Design, synthesis and structure-activity relationship study of novel pyrazole-based heterocycles as potential antitumor agents.
Farag AM; Ali KA; El-Debss TM; Mayhoub AS; Amr AG; Abdel-Hafez NA; Abdulla MM
Eur J Med Chem; 2010 Dec; 45(12):5887-98. PubMed ID: 20950898
[TBL] [Abstract][Full Text] [Related]
18. Design, synthesis and evaluation of antiinflammatory, analgesic and ulcerogenicity studies of novel S-substituted phenacyl-1,3,4-oxadiazole-2-thiol and Schiff bases of diclofenac acid as nonulcerogenic derivatives.
Bhandari SV; Bothara KG; Raut MK; Patil AA; Sarkate AP; Mokale VJ
Bioorg Med Chem; 2008 Feb; 16(4):1822-31. PubMed ID: 18248993
[TBL] [Abstract][Full Text] [Related]
19. Design, Synthesis, and Antitumor Activity of Novel 5-Pyridyl-1,3,4-oxadiazole Derivatives against the Breast Cancer Cell Line MCF-7.
Khalil NA; Kamal AM; Emam SH
Biol Pharm Bull; 2015; 38(5):763-73. PubMed ID: 25947922
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and antiproliferative assay of 1,3,4-oxadiazole and 1,2,4-triazole derivatives in cancer cells.
Tu G; Yan Y; Chen X; Lv Q; Wang J; Li S
Drug Discov Ther; 2013 Apr; 7(2):58-65. PubMed ID: 23715503
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
